“Prognostic Value And Clinical Impact Of EBV And PDL1 Expression In Classical Hodgkin Lymphoma”. Journal of Pharmaceutical Negative Results, Feb. 2023, pp. 3461-72, https://doi.org/10.47750/pnr.2023.14.02.406.